Seer, Inc. Class A Common Stock (SEER) Stock Price
SEERStock
$2.03−8.14%52W
Market Cap$112.41M
P/E—
PEG Ratio—
Div yield0.00%
Beta1.42
SEER Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-5.27%
Price vs S&P 500 (4W)10.46%
VGM Score46.33
Indicated Dividend Yield (Annual)0.00%
SEER Earnings Surprise History
| Quarter | Report date | EPS estimate | EPS actual | Surprise |
|---|---|---|---|---|
| Q2 2026 | -$0.27 | -$0.31 | -14.81%(-$0.04) | |
| Q1 2026 | -$0.29 | -$0.30 | -1.69%(-$0.01) | |
| Q4 2025 | -$0.32 | -$0.29 | +9.38%(+$0.03) | |
| Q3 2025 | -$0.30 | -$0.32 | -6.67%(-$0.02) | |
| Q2 2025 | -$0.37 | -$0.33 | +11.30%(+$0.04) |
SEER Analyst Recommendations
Jun 2026
Jul 2026
Aug 2026
Sep 2026
4.13
4.13
4.13
4.13
Industry Peers — Lab Analytical Instruments(25)
| Symbol | Value Score | Growth Score | Momentum Score | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|---|---|---|
SEERSeer, Inc. Class A Common Stock | C | D | C | 7.9x | 90.5% | 47.7% | -498.2% | $2.03 |
| AAgilent Technologies Inc. | D | C | A | 6.6x | 5.4% | 53.9% | 22.2% | $172.97 |
| WATWaters Corp | F | C | A | 9.4x | 6.0% | 50.9% | 7.1% | $436.95 |
| ILMNIllumina Inc | D | D | A | 8.8x | 6.0% | 66.4% | 19.5% | $262.54 |
| MTDMettler-Toledo International | D | C | A | 7.9x | 5.5% | 60.3% | 26.6% | $1622.29 |
| RVTYRevvity, Inc. | D | D | A | 5.8x | -5.5% | 55.0% | 12.3% | $152.64 |
| AVTRAvantor, Inc. | C | F | A | 1.7x | 0.5% | 31.8% | -4.7% | $16.42 |
| BIO.BBio-Rad Laboratories, Inc. Class B | C | D | B | 3.7x | 0.3% | 51.9% | 1.8% | $364.15 |
| BIOBio-Rad Laboratories, Inc.Class A | C | D | B | 3.7x | 0.3% | 51.9% | 1.8% | $353.70 |
| TXG10x Genomics, Inc. Class A Common Stock | F | D | A | 14.8x | 16.6% | 69.6% | -14.3% | $69.86 |
| BRKRBruker Corporation | D | D | B | 2.4x | 11.6% | 47.7% | -1.5% | $54.80 |
About Seer, Inc. Class A Common Stock
Seer Inc provides proteomics solutions for researchers using proprietary engineered nanoparticle technology. Its Proteograph Product Suite enables rapid, unbiased analysis of the complete protein profile (proteome) in biological samples at scale. This addresses a key need in life science research by delivering comprehensive protein analysis capabilities.